A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI)

Clinical trial NCT00676702 · COMPLETED

Trial details

NCT number: NCT00676702
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Exocrine Pancreatic Insufficiency Pancreatitis, Chronic Steatorrhea Pancreatitis

Start date: 2008-07-01
Primary completion: 2009-01-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.